Machine Readiness
Stored receipt and evidence
16
55
0
0
0
Samples
No stored offer samples.
Samples
No stored action samples.
Samples
No stored product samples.
Document
User-agent: * Disallow: /search Disallow: /preview/ Disallow: /*[*]* Sitemap: https://www.managedhealthcareexecutive.com/sitemap.xml Sitemap: https://www.managedhealthcareexecutive.com/sitemap-news.xml
Document
# Managed Healthcare Executive > Managed Healthcare Executive - Healthcare Publication - Base URL: https://www.managedhealthcareexecutive.com - Generated: 2026-04-25T03:38:54.598Z - Content updates: multiple times daily ## Content Access for AI Agents This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML. **Supported content types:** - `text/markdown` — Clean Markdown with YAML frontmatter - `text/plain` — Plain text (same as Markdown) - `text/html` — Default HTML response **Example request:** ``` curl -H "Accept: text/markdown" https://www.managedhealthcareexecutive.com/view/article-slug ``` **YAML frontmatter schema** (returned with every Markdown response): | Field | Type | Description | |-------|------|-------------| | `title` | string | Article headline | | `description` | string | Summary/excerpt (max 300 chars) | | `url` | string | Canonical article URL | | `canonical_url` | string | Canonical URL if different from `url` | | `published` | ISO 8601 | Original publication date | | `modified` | ISO 8601 | Last modification date | | `authors` | string[] | Author display names | | `content_type` | string | Content category (e.g., "News", "Clinical") | | `categories` | string[] | Taxonomy categories | | `tags` | string[] | SEO tags | | `image` | string | Featured image URL | | `publisher` | string | Publication/site name | **Discovery headers** (included on all responses): - `Link: <https://www.managedhealthcareexecutive.com/llms.txt>; rel="llms"` — RFC 8288 link to this file - `X-Llms-Txt: https://www.managedhealthcareexecutive.com/llms.txt` — Explicit discovery header ## Usage Policy - Robots policy: [https://www.managedhealthcareexecutive.com/robots.txt](https://www.managedhealthcareexecutive.com/robots.txt) - Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329) - Rate guidance: prefer RSS and sitemap feeds over crawling individual pages - Attribution: All content © MJH Life Sciences. Include source URLs when citing. ## Content Categories - [Between the Lines](https://www.managedhealthcareexecutive.com/between-the-lines) - [Business](https://www.managedhealthcareexecutive.com/business) - [Clinical](https://www.managedhealthcareexecutive.com/clinical) - [Contributed](https://www.managedhealthcareexecutive.com/contributed) - [Discussion](https://www.managedhealthcareexecutive.com/discussion) - [Emerging Leaders in Healthcare](https://www.managedhealthcareexecutive.com/emerging-leaders-in-healthcare) - [Formulary Watch](https://www.managedhealthcareexecutive.com/formulary-watch) - [K-Cast](https://www.managedhealthcareexecutive.com/k-cast) - [NO ADS](https://www.managedhealthcareexecutive.com/noads) - [News](https://www.managedhealthcareexecutive.com/news) - [PBMI Innovators](https://www.managedhealthcareexecutive.com/pbmi-innovators) - [Population Health Perspectives](https://www.managedhealthcareexecutive.com/population-health-perspectives) - [Publications](https://www.managedhealthcareexecutive.com/journals) - [Resources](https://www.managedhealthcareexecutive.com/resources) - [Sponsored Content](https://www.managedhealthcareexecutive.com/sponsored-content) - [Sponsored Resources](https://www.managedhealthcareexecutive.com/sponsored-resources) - [Vaccines: 2023 Year in Review](https://www.managedhealthcareexecutive.com/clinical/vaccines-2023-year-in-review) - [Video Series](https://www.managedhealthcareexecutive.com/video-series) ## Featured Content - [FDA grants priority vouchers to 3 psychedelic medications](https://www.managedhealthcareexecutive.com/view/fda-grants-priority-vouchers-to-3-psychedelic-medications): This action follows an Executive Order issued earlier this week to speed review of psychedelic drugs that have shown potential to treat serious menta... - [UCSF-led hypertension strategy improves blood pressure control across UC Health](https://www.managedhealthcareexecutive.com/view/ucsf-led-hypertension-strategy-improves-blood-pressure-control-across-uc-health): A UC Health system-wide hypertension medication algorithm improved blood pressure control across tens of thousands of patients and was associated with... - [Health plans report 11% reduction in prior authorization](https://www.managedhealthcareexecutive.com/view/health-plans-report-11-reduction-in-prior-authorization): Major health insurers say they have cut prior authorizations, but the AMA says physicians report that the burden of prior authorization remains high. - [Facing the practical problems of gene therapy | AMCP Annual 2026](https://www.managedhealthcareexecutive.com/view/facing-the-practical-problems-of-gene-therapy-amcp-annual-2026) - [Study reveals airway ‘resistome’ larger in those chronic lung disease](https://www.managedhealthcareexecutive.com/view/study-reveals-airway-resistome-larger-in-those-chronic-lung-disease): The resistome is the term for resistance genes present in both harmful and nonharmful bacteria. In the lung, this genetic reservoir can be shaped by f... - [FDA approves the first gene therapy for genetic hearing loss](https://www.managedhealthcareexecutive.com/view/fda-approves-the-first-gene-therapy-for-genetic-hearing-loss): Regeneron is making Otarmeni, which treats patients with biallelic variants in the OTOF gene, available at no cost. This is the second therapy that wa... - [Skin cells may help rabies virus spread to the nervous system](https://www.managedhealthcareexecutive.com/view/skin-cells-may-help-rabies-virus-spread-to-the-nervous-system): Skin cells can actively help the rabies virus multiply and pass into nearby nerve cells, explaining how even small bites or scratches, particularly fr... - [What the introduction of bispecific antibodies has meant for the treatment of multiple myeloma](https://www.managedhealthcareexecutive.com/view/what-the-introduction-of-bispecific-antibodies-has-meant-for-the-treatment-of-multiple-myeloma): Bispecific antibodies are highly efficacious and have a milder side effect profile than other late-line treatments for multiple myeloma, according to... - [An overview of the prevalence and treatment of multiple myeloma ](https://www.managedhealthcareexecutive.com/view/an-overview-of-the-prevalence-and-treatment-of-multiple-myeloma): Multiple myeloma accounts for only 1.8% of cancers, but it is the second-most common blood cancer, with approximately 36,000 new cases diagnosed each... - [FDA approves antiretroviral Idvynso for adults with HIV](https://www.managedhealthcareexecutive.com/view/fda-approves-antiretroviral-idvynso-for-adults-with-hiv): The FDA has approved Merck’s once-daily single-tablet HIV treatment Idvynso (doravirine/islatravir) for virologically suppressed adults, based on phas... ## Feeds and Indexes - [RSS Feed](https://www.managedhealthcareexecutive.com/rss.xml): Latest articles in XML syndication format - [Sitemap](https://www.managedhealthcareexecutive.com/sitemap.xml): Complete URL index for all published pages - [News Sitemap](https://www.managedhealthcareexecutive.com/sitemap-news.xml): Recent articles optimized for news indexing - [Authors Directory](https://www.managedhealthcareexecutive.com/authors): Browse all contributors and their published work
Document
Not stored for this site.